Tag: PharmAust
PharmAust: Completes enrolment of second patient cohort in MND/ALS trial
PharmAust Completes enrolment of second patient cohort in MND/ALS trialPharmAust (PAA) completes the enrolment of the second cohort...
PharmAust: Reports ongoing positive outcomes for canine cancer treatment
PharmAust Reports ongoing positive outcomes for canine cancer treatmentPharmAust (PAA) claims a 12-year-old beagle in its clinical trial...
PharmAust: Gets approval to increase dosage in MPL trial
PharmAust Gets approval to increase dosage in MPL trialPharmAust (PAA) has received the green light from the trial...
PharmAust: Receives first $200k instalment for Phase 1 MND trial, appoints trial manager
PharmAust Receives first $200k instalment for Phase 1 MND trial, appoints trial managerClinical-stage biotechnology company PharmAust (PAA) receives...
PharmAust: Successfully produces smaller GMP tablets
PharmAust Successfully produces smaller GMP tabletsPharmAust’s (PAA) upcoming human trials receives a major boost as the company’s GMP...
PharmAust: Completes investigations on COVID-19 infection agent
PharmAust: Completes investigations on COVID-19 infection agentPharmAust (PAA) has investigated the effects of monepantel (MPL) and monepantel sulfone...
PharmAust: Begins recruiting dogs for canine cancer trial
PharmAust (PAA) has officially started recruiting patients for a second-phase clinical trial testing one of its key drugs...
PharmAust: Continues research in neglected diseases
Clinical oncology company PharmAust (PAA) has secured an extension on its current contract with the Drugs for Neglected...
PharmAust: Awarded $881K grant for phase one monepantel trial
PharmAust (PAA) has granted $881,085 for a phase one clinical trial of monepantel in patients with Motor Neurone...
PharmAust: Continues testing COVID-19 treatment
PharmAust (PAA) has revealed preliminary results show its drugs are effective in inhibiting COVID-19 in human lung cells
...
PharmAust: Sees positive results for canine cancer treatment
PharmAust: Sees positive results for canine cancer treatmentOncology company PharmAust (PAA) has found success in its canine cancer...
PharmAust: Successfully progresses canine trials and other operations
PharmAust: Successfully progresses canine trials and other operationsPharmAust (PAA) claims its business progressed "very successfully" in the 2019...